Retinal ganglion cell protection by hop-flower extract as a novel neuroprotective strategy for glaucoma  

作　　者：Tomoko Hasegawa Hanako Ohashi Ikeda 

机构地区：[1]Department of Ophthalmology and Visual Sciences,Kyoto University Graduate School of Medicine,Kyoto,Japan [2]Research Fellow of Japan Society for the Promotion of Science,Tokyo,Japan

出　　处：《Neural Regeneration Research》2022年第6期1267-1268,共2页中国神经再生研究（英文版）

基　　金：research grants from the Ministry of Health,Labour and Welfare of Japan(to HOI).

摘　　要：In glaucoma,a leading cause of blindness,retinal ganglion cells are progressively damaged.Intraocular pressure reduction is the only established treatment for glaucoma(Collaborative Normal-Tension Glaucoma Study Group,1998;Vass et al.,2007).However,in some cases,visual field loss progresses despite sufficiently reduced intraocular pressure(Collaborative Normal-Tension Glaucoma Study Group,1998;Killer and Pircher,2018).While intraocular pressure and age are known risk factors for glaucoma(Ernest et al.,2013),the underlying mechanisms of glaucoma progression are not fully understood.

关 键 词：GLAUCOMA al. protective 

分 类 号：R285[医药卫生—中药学]